AHP Develops Feverfew Monograph, Reference Standard

July 30, 2007

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

SCOTTS VALLEY, Calif.The American Herbal Pharmacopoeia (AHP) released its newest monograph, Feverfew Aerial Parts (Tanacetum parthenium) Standards of Analysis, Quality Control and Therapeutics, as well as an AHP-verified botanical reference standard. Feverfew has been traditionally used as an antipyretic and is commonly used for prevention and treatment of migraine headache, as well as asthma, rheumatoid arthritis and psoriasis. The monograph provides an up-to-date assessment of traditional and scientific data, provides methods of analysis and identification, and reviews issues surrounding the use of parthenolide as a marker compound. In addition, the feverfew reference standard material has been botanically, physically and chemically characterized to assist companies in developing internal quality control specs and aid in laboratory testing. In addition to the feverfew monograph, AHP (www.Herbal-AHP.org) offers more than 100 botanical reference materials.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like